Nonstructured Treatment Interruptions Among Injection Drug Users in Baltimore, MD

被引:43
作者
Kavasery, Ravi [1 ]
Galai, Noya [1 ,2 ]
Astemborski, Jacquie [1 ]
Lucas, Gregory M. [3 ]
Celentano, David D. [1 ]
Kirk, Gregory D. [1 ,3 ]
Mehta, Shruti H. [1 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[2] Univ Haifa, Dept Stat, IL-31999 Haifa, Israel
[3] Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA
关键词
highly active antiretroviral therapy; injection drug users; treatment interruptions; ACTIVE ANTIRETROVIRAL THERAPY; IMMUNODEFICIENCY-VIRUS-INFECTION; DISEASE PROGRESSION; COHORT; HIV-1; ADHERENCE; MORTALITY; PATTERNS; IMPACT;
D O I
10.1097/QAI.0b013e318198a800
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: We characterized patterns of highly active antiretroviral therapy (HAART) use and predictors of nonstructured treatment interruptions (NTIs) among injection drug users (IDUs) in Baltimore, MD. Methods: Three hundred thirty-five IDUs who initiated HAART from 1996 to 2006 were studied. NTIs were defined as any subsequent 6-month interval where HAART was not reported. Predictors of the first NTI and subsequent restart of HAART-were examined using Cox regression. Results: Two hundred sixty (78%) reported >= NTI. Of 215 with >= 1 follow-up visit after the NTI, 44 (20%) never restarted HAART, 62 (29%) restarted and remained on HAART, and 109 (51%) reported multiple NTIs. NTIs were less likely among those who initiated HAART in later calendar years and had a recent outpatient visit and more likely among women, persons with detectable HIV RNA at the prior visit, and those who reported injecting daily. Among those with NTIs, interuptions occurred earlier in persons who were younger, who did not have a prior AIDS diagnosis, and who were actively injecting; NTIs lasted longer in persons who had higher HIV RNA levels, in persons who were incarcerated, and in persons drinking alcohol. A recent outpatient visit and not actively injecting were associated with restarting HAART. Conclusions: NTIs were common in this population and occurred most frequently in the setting of active drug use and disruption of health care. Effective linkages between primary care for HIV and substance abuse treatment may improve HAART outcomes in this population.
引用
收藏
页码:360 / 366
页数:7
相关论文
共 19 条
[1]   CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1:: results of the Staccato randomised trial [J].
Ananworanich, Jintanat ;
Gayet-Ageron, Angele ;
Le Braz, Michelle ;
Prasithsirikul, Wisit ;
Chetchotisakd, Ploenchan ;
Kiertiburanakul, Sasisopin ;
Munsakul, Warangkana ;
Raksakulkarn, Phitsanu ;
Tansuphasawasdikul, Somboon ;
Sirivichayakul, Sunee ;
Cavassini, Matthias ;
Karrer, Urs ;
Genne, Daniel ;
Nueesch, Reto ;
Vernazza, Pietro ;
Bernasconi, Enos ;
Leduc, Dominic ;
Satchell, Claudette ;
Yerly, Sabine ;
Perrin, Luc ;
Hill, Andrew ;
Perneger, Thomas ;
Phanuphak, Praphan ;
Furrer, Hansjakob ;
Cooper, David ;
Ruxrungtham, Kiat ;
Hirschel, Bernard .
LANCET, 2006, 368 (9534) :459-465
[2]   Time to initiating highly active antiretroviral therapy among HIV infected injection drug users [J].
Celentano, DD ;
Galai, N ;
Sethi, AK ;
Shah, NG ;
Strathdee, SA ;
Vlahov, D ;
Gallant, JE .
AIDS, 2001, 15 (13) :1707-1715
[3]  
DARMINIO MA, 2005, J ACQ IMMUN DEF SYND, V38, P407
[4]  
El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360
[5]   Longitudinal patterns of drug injection behavior in the ALIVE study cohort, 1988-2000: Description and determinants [J].
Galai, N ;
Safaeian, M ;
Vlahov, D ;
Bolotin, A ;
Celentano, DD .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 158 (07) :695-704
[6]   Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women [J].
Kapadia, Farzana ;
Vlahov, David ;
Wu, Yingfeng ;
Cohen, Mardge H. ;
Greenblatt, Ruth M. ;
Howard, Andrea A. ;
Cook, Judith A. ;
Goparaju, Lakshmi ;
Golub, Elizabeth ;
Richardson, Jean ;
Wilson, Tracey E. .
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2008, 34 (02) :161-170
[7]   Improving survival among HIV-infected injection drug users: How should we define success? [J].
Kirk, Gregory D. ;
Vlahov, David .
CLINICAL INFECTIOUS DISEASES, 2007, 45 (03) :377-380
[8]  
Li XH, 2005, JAIDS-J ACQ IMM DEF, V38, P320
[9]   Illicit drug use and HIV-1 disease progression: A longitudinal study in the era of highly active antiretroviral therapy [J].
Lucas, GM ;
Griswold, M ;
Gebo, KA ;
Keruly, J ;
Chaisson, RE ;
Moore, RD .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 163 (05) :412-420
[10]  
Lucas GM, 2001, J ACQ IMMUN DEF SYND, V27, P251, DOI 10.1097/00126334-200107010-00006